Double-pulse induction cell stimulation noninvasive regeneration device
Through the precise control and customizable solution of the non-invasive regeneration device of dual-pulse induction cell stimulation, the problems of limitations and insufficient adaptability in existing PEMF technology are solved, and more comprehensive tissue regeneration and pain management are achieved, improving user experience and data management capabilities significantly improve treatment effectiveness and safety.
Patent Information
- Application Number
- CN202411116936.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-22
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing PEMF technology has problems such as limitations in tissue regeneration and pain management, insufficient adaptability, insufficient deep tissue stimulation, poor user experience, insufficient comprehensive treatment effect, and insufficient data tracking and analysis capabilities.
Using dual-pulse induction cell stimulation non-invasive regeneration devices, including microcontrollers, power management units, output channels, dual coils and user interfaces, provides customized treatment options and detailed data recording function.
Significantly improve treatment effect, enhance adaptability, improve deep tissue stimulation, enhance user experience, provide more comprehensive pain relief and inflammation control, enhance data management capabilities, and improve device safety and future scalability .
Smart Images

Figure CN118987500A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of medical devices, in particular to a double-pulse induction cell stimulation non-invasive regeneration device. Background Art
[0002] Pulsed electromagnetic field (PEMF) technology has been used in the medical field for decades, especially in tissue regeneration and pain management. Since the 1970s, PEMF technology has shown great potential in fracture healing, soft tissue repair and nerve regeneration. However, with the deepening of medical research, the limitations of existing PEMF technology have gradually become apparent.
[0003] Traditional PEMF devices usually use pulses of a single frequency, such as a fixed frequency of 15Hz or an adjustable frequency range of 5-30Hz. This single-frequency stimulation mode does show positive effects in some applications, but its effects are often limited and it is difficult to meet the diverse needs of different types of tissues and different treatment stages. For example, in different stages of fracture healing (inflammatory phase, repair phase, remodeling phase), the optimal response frequency of cells to electromagnetic stimulation may vary significantly. Single-frequency PEMF devices are difficult to adapt to such dynamically changing needs.
[0004] In addition, although some improved PEMF devices in the prior art have introduced a dual-pulse system, they lack precise pulse control and advanced coil design. This results in uneven magnetic field distribution, unstable stimulation effects, and difficulty in achieving effective treatment of deep tissues. At the same time, these devices often lack a user-friendly interface and flexible parameter adjustment functions, limiting their widespread application in clinical practice.
[0005] The main problems faced by existing PEMF technology include:
[0006] 1. Limited stimulation effect: Single-frequency stimulation is difficult to fully activate different types of cells, resulting in less than ideal treatment effects.
[0007] 2. Insufficient adaptability: Fixed or limited adjustable frequency ranges are difficult to meet the needs of different patients and different treatment stages.
[0008] 3. Insufficient deep tissue stimulation: Due to the lack of advanced coil design and precise magnetic field control, it is difficult to effectively stimulate deep tissue.
[0009] 4. Poor user experience: Complex operations and limited customizability reduce patient treatment compliance.
[0010] 5. Insufficient effect of comprehensive treatment: While promoting tissue regeneration, it has limited effects on pain management and inflammation control.
[0011] 6. Insufficient data tracking and analysis capabilities: The lack of detailed treatment data recording and analysis functions makes it difficult to achieve personalized treatment and long-term effect evaluation.
[0012] In view of these problems, it is extremely necessary to develop devices that can provide more precise, flexible and effective cell stimulation programs. Such devices should not only be able to adapt to different types of tissue regeneration needs, but also be able to provide comprehensive therapeutic effects, including promoting tissue repair, relieving pain and controlling inflammation. Summary of the invention
[0013] The present invention provides a dual pulse induction cell stimulation non-invasive regeneration device, which is intended to promote cell activity and tissue regeneration through precisely controlled electromagnetic pulses. The device is particularly suitable for the fields of fracture healing, nerve regeneration and chronic wound treatment.
[0014] The present invention provides a double pulse induction cell stimulation non-invasive regeneration device, comprising:
[0015] a microcontroller for controlling the operation of the device;
[0016] a power management unit, electrically connected to the microcontroller, for regulating input voltage and supplying power to the device;
[0017] At least two output channels, each of the output channels comprising:
[0018] a boost converter for generating an output voltage;
[0019] an optical coupler for controlling the intensity of the output voltage;
[0020] MOSFET array for generating output pulse signal;
[0021] A double coil, electrically connected to the MOSFET array, for generating a magnetic field pulse;
[0022] a user interface, electrically connected to the microcontroller, for receiving user input and displaying device status;
[0023] A storage unit is electrically connected to the microcontroller and is used to store treatment plans and device settings.
[0024] Specifically, the at least two output channels include a primary output channel and a secondary output channel, wherein:
[0025] The main output channel is used to generate pulses of a first frequency;
[0026] The secondary output channel is used to generate pulses of a second frequency, the second frequency being different from the first frequency;
[0027] The pulses of the main output channel and the secondary output channel are kept synchronous.
[0028] Specifically, the double coil comprises:
[0029] A first coil connected to the main output channel;
[0030] A second coil is connected to the secondary output channel,
[0031] The first coil and the second coil have the same specifications.
[0032] Specifically, it also includes an SD card interface, which is electrically connected to the microcontroller for data exchange and firmware update.
[0033] Specifically, the user interface includes a touch screen for displaying device status and receiving user input.
[0034] Specifically, the microcontroller is further used to control each of the output channels to generate a pulse with a duration of 200 microseconds, including a rising / positive phase of 100 microseconds and a falling / negative phase of 100 microseconds.
[0035] Specifically, it also includes multi-layer protection mechanisms, including:
[0036] Fuse, for over-current protection;
[0037] TVS diode for overvoltage protection;
[0038] Schottky diode for reverse voltage protection.
[0039] Specifically, the power management unit includes an LM2733YMF boost converter for operating within an input voltage range of 4.5V to 40V; the MOSFET array includes an IRF7343TRPBF N / P channel MOSFET for fast switching and high efficiency operation; and the optocoupler is a TLP291-4 model for providing electrical isolation and noise suppression.
[0040] Specifically, the microcontroller is also used for:
[0041] receiving treatment parameters input by a user;
[0042] generating a control signal based on the treatment parameter;
[0043] Sending the control signal to the corresponding output channel,
[0044] The treatment parameters include pulse frequency, pulse intensity and treatment duration.
[0045] Specifically, it also includes a modular housing for accommodating various components of the device and facilitating maintenance and upgrading.
[0046] The beneficial effects of the present invention are mainly reflected in the following aspects:
[0047] 1. Improve the treatment effect: The dual pulse system can activate different types of cells more comprehensively, significantly increase the bone density increase rate (18.5%) and callus volume (32.7cm 3 ), far exceeding traditional single-pulse devices.
[0048] 2. Enhanced adaptability: Customizable treatment plans enable the device to adapt to the needs of different patients and different treatment stages, improving the targetedness and effectiveness of treatment.
[0049] 3. Improved deep tissue stimulation: Advanced dual coil design and precise pulse control allow for more effective stimulation of deep tissues, expanding the application range of treatment.
[0050] 4. Improve user experience: The intuitive user interface and flexible parameter adjustment function greatly improve treatment compliance (95%), which helps to ensure the treatment effect.
[0051] 5. Comprehensive therapeutic effect: In addition to promoting tissue regeneration, the present invention also performs well in pain relief (68% improvement) and inflammation control (72% decrease), providing a more comprehensive treatment plan.
[0052] 6. Enhanced data management capabilities: The integrated storage unit and SD card interface allow detailed recording and analysis of treatment data, providing a basis for personalized treatment and long-term effect evaluation.
[0053] 7. Improved security: Multi-layer protection mechanism ensures the safety and reliability of the device in various usage environments.
[0054] 8. Future scalability: Modular design facilitates future technology upgrades and expansion of new application areas.
[0055] In summary, the present invention not only solves the main problems faced by existing PEMF technology, but also achieves significant improvements in treatment effect, adaptability, user experience and safety. This innovative dual-pulse induction cell stimulation non-invasive regeneration device is expected to open up new treatment methods in the fields of regenerative medicine, pain management and inflammation control, providing patients with better quality and more personalized treatment options. BRIEF DESCRIPTION OF THE DRAWINGS
[0056] Figure 1 This is a schematic diagram of the framework of the double-pulse induction cell stimulation non-invasive regeneration device of the present invention.
[0057] Figure 2It is a schematic diagram of the framework of the output channel of the present invention. DETAILED DESCRIPTION
[0058] In order to further explain the technical means and effects adopted by the present invention to achieve the predetermined invention purpose, the specific implementation methods, structures, features and effects are described in detail below in conjunction with the accompanying drawings and preferred embodiments. In the following description, different "one embodiment" or "another embodiment" does not necessarily refer to the same embodiment. In addition, specific features, structures or characteristics in one or more embodiments may be combined in any suitable form.
[0059] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
[0060] The present invention relates to the field of medical devices, in particular to non-invasive devices for cell stimulation and tissue regeneration.
[0061] Please refer to Figure 1 The dual pulse induction cell stimulation non-invasive regeneration device of the present invention includes the following main components: a microcontroller 1, a power management unit 2, at least two output channels 3, a user interface 4 and a storage unit 5.
[0062] Microcontroller 1 is the core control unit of the device, using the STM32F103RCT6 model. It is responsible for coordinating the work of various components, processing user input, controlling output parameters, and managing data storage. In the application scenario of fracture healing, microcontroller 1 can adjust the treatment parameters according to the specific situation of the fracture (such as fracture site, healing stage). For example, in the early stage of fracture, a lower frequency pulse (such as 5Hz) may be required to reduce inflammation; while in the callus formation stage, a higher frequency pulse (such as 15Hz) may be required to promote bone cell proliferation.
[0063] The power management unit 2 uses the LM2733YMF boost converter, which can operate over a wide input voltage range of 4.5V to 40V. This design allows the device to adapt to various power supply conditions, whether it is using a standard power supply in a hospital or a battery-powered device at home, it can maintain a stable output. For example, when performing home treatment for chronic wounds, patients can use a portable battery to power the device without worrying about power fluctuations affecting the treatment effect.
[0064] Please refer to Figure 2 The output channel 3 is the core part of the present invention, including the main output channel and the secondary output channel. Each channel includes the following components:
[0065] a) Boost converter 31: used to boost the power supply voltage to a desired output voltage. In nerve regeneration therapy, a higher voltage (eg, 30V) may be required to generate a magnetic field of sufficient strength to stimulate deep neural tissue.
[0066] b) Optocoupler 32: Model TLP291-4 is used to control the intensity of the output voltage. It provides electrical isolation to ensure patient safety while suppressing noise and improving signal quality. Signal clarity is critical when dealing with delicate neural stimulation.
[0067] c) MOSFET array 33: IRF7343TRPBF N / P channel MOSFET is used to generate precise output pulse signals. Its fast switching characteristics (switching time can reach tens of nanoseconds) ensure precise control of the pulse shape. In fracture healing treatment, precise pulse shape can more effectively stimulate bone cells and promote callus formation.
[0068] d) Dual coil 34: electrically connected to the MOSFET array, used to generate magnetic field pulses. The dual coil design includes two coils of the same specifications (40mm inner diameter, 52 turns, 0.4mm wire diameter, 3mm height), one connected to the main output channel and the other connected to the secondary output channel. This design allows for the generation of complex magnetic field distributions to better simulate electromagnetic field changes in the natural environment. For example, in the treatment of chronic wounds, the main coil can be used to generate stronger pulses to stimulate deep tissues, while the secondary coil can be used to generate a weaker background magnetic field to maintain the activity of surface cells.
[0069] The pulses of the main output channel and the secondary output channel remain synchronized, but the frequencies can be different. For example, in nerve regeneration therapy, the main output channel can be set to 10Hz (simulating the normal nerve discharge frequency) and the secondary output channel to 75Hz (providing continuous background stimulation). This dual-pulse system can stimulate neurons more effectively and promote axon regeneration.
[0070] The user interface 4 is designed with a touch screen, which is easy for doctors or patients to operate. It displays information such as current treatment parameters and remaining time, and allows users to adjust settings. For example, in fracture healing treatment, doctors can adjust the pulse intensity and frequency in real time through the touch screen according to the X-ray results to adapt to different stages of callus formation.
[0071] The storage unit 5 uses a BL24C256A chip and provides 256Kbit storage space. It is used to store multiple preset treatment plans and device settings. For example, treatment plans for different types of fractures (such as long bones and flat bones) can be stored to facilitate doctors to quickly select and apply them.
[0072] In addition, the present invention also includes the following features:
[0073] 1. SD card interface: electrically connected to the microcontroller for data exchange and firmware updates. This allows the device to record detailed treatment data (such as parameters and duration of each treatment) for long-term tracking and analysis by doctors. In the treatment of chronic wounds, this data can help doctors assess the progress of healing and adjust treatment strategies accordingly.
[0074] 2. Multi-layer protection mechanism: including 2A fuse (for overcurrent protection), SMAJ28CA TVS diode (for overvoltage protection) and SS34 Schottky diode (for reverse voltage protection). These protection measures ensure the safety and reliability of the device in various usage environments. For example, in home use scenarios, these protection mechanisms can prevent the device from being damaged or causing harm to the patient even if the patient accidentally uses an inappropriate power adapter.
[0075] 3. Pulse control: The microcontroller controls each output channel to generate a pulse with a duration of 200 microseconds, including a 100 microsecond rise / positive phase and a 100 microsecond fall / negative phase. This symmetrical pulse shape helps balance the distribution of ions inside and outside the cell, reducing ion accumulation that may result from long-term use. In nerve regeneration therapy, this precise pulse control can stimulate neurons more effectively while reducing unnecessary cell stress responses at the same time. For example, in the treatment of peripheral nerve injuries, this precise pulse can simulate natural nerve impulses and promote axon regeneration without overstimulation causing cell fatigue.
[0076] 4. Modular housing: used to house the various components of the device and facilitate maintenance and upgrades. This design not only improves the durability of the device, but also leaves room for future technological upgrades. For example, if a more efficient coil design is developed in the future, only the coil module needs to be replaced without replacing the entire device. This is particularly important in clinical applications because it allows medical institutions to maintain the advanced nature of the equipment at minimal cost.
[0077] 5. Treatment parameter control: The microcontroller receives the treatment parameters input by the user, including pulse frequency, pulse intensity and treatment duration. Based on these parameters, the microcontroller generates corresponding control signals and sends them to the corresponding output channels. This flexible parameter control allows the device to adapt to different treatment needs. For example, at different stages of fracture healing, the parameters can be adjusted:
[0078] Inflammatory phase (1-7 days): low frequency (such as 5 Hz), low intensity, short time (such as 15 minutes / time)
[0079] Recovery period (1-8 weeks): medium frequency (such as 15Hz), medium intensity, longer time (such as 30 minutes / time)
[0080] Remodeling phase (weeks to months): high frequency (eg, 30 Hz), high intensity, long duration (eg, 45 minutes / time)
[0081] This precise parameter control allows doctors to personalize treatment based on the patient's recovery.
[0082] In practical application, the use process of this device is as follows:
[0083] 1. The doctor or operator selects an appropriate treatment plan through the touch screen user interface 4, or enters custom parameters.
[0084] 2. The microcontroller 1 reads the corresponding treatment plan from the storage unit 5, or receives custom parameters.
[0085] 3. The power management unit 2 ensures a stable power supply.
[0086] 4. The microcontroller 1 generates a control signal according to the treatment plan and sends it to the primary output channel and the secondary output channel.
[0087] 5. The boost converter of each output channel generates the required output voltage according to the control signal.
[0088] 6. The optocoupler precisely controls the intensity of the output voltage to ensure the safety and effectiveness of the treatment.
[0089] 7. The MOSFET array generates precise pulses according to the control signal.
[0090] 8. The double coils receive pulse signals and generate the magnetic field required for treatment.
[0091] 9. During the entire treatment process, a multi-layer protection mechanism continuously monitors and protects the operation of the device.
[0092] 10. Treatment data is recorded through the SD card interface to facilitate subsequent analysis and treatment plan optimization.
[0093] For example, in a typical fracture healing application, a physician might use the device as follows:
[0094] 1. Early stage of fracture: The doctor selects the "fracture healing-inflammation phase" program, and the device is automatically set to 5 Hz frequency, 20% intensity, 3 times a day, 15 minutes each time.
[0095] 2. Follow-up after 2 weeks: X-rays showed that bone callus began to form, and the doctor adjusted the regimen to "fracture healing-repair period", increasing the frequency to 15 Hz and the intensity to 50%, twice a day, 30 minutes each time.
[0096] Follow-up after 3.6 weeks: callus formation was good, and the doctor adjusted the plan again to "fracture healing-remodeling period", with the frequency set to 25 Hz, intensity 70%, once a day, 45 minutes.
[0097] 4. After the treatment, the doctor will export the treatment data through the SD card to analyze the patient's recovery process and provide reference for similar cases in the future.
[0098] The dual pulse induction cell stimulation non-invasive regeneration device of the present invention provides a powerful and versatile tool for various cell stimulation and tissue regeneration applications through its precise control, flexible parameter adjustment and comprehensive safety protection. It can be applied not only to fracture healing, but also to multiple fields such as nerve regeneration, chronic wound healing, and soft tissue repair. For example, in nerve regeneration therapy, the dual pulse system can be used to simulate natural neural electrical activity and promote axon growth; in chronic wound treatment, angiogenesis and cell proliferation can be promoted through precisely controlled magnetic field pulses.
[0099] In addition, the modular design and data logging capabilities of the device also facilitate future research and improvements. Researchers can analyze large amounts of treatment data to optimize treatment parameters for different types of diseases and may even discover new areas of application.
[0100] In summary, the present invention provides a highly flexible, precisely controllable, safe and reliable cell stimulation device, which is expected to play an important role in the field of regenerative medicine and provide patients with better non-invasive treatment options.
[0101] In order to verify the effectiveness of the present invention, the applicant will provide an embodiment and three comparative examples for this dual pulse induction cell stimulation non-invasive regeneration device, and give detailed test results and analysis.
[0102] Embodiment 1 (the present invention):
[0103] The double-pulse induction cell stimulation non-invasive regeneration device of the present invention has a main output channel (10 Hz) and a secondary output channel (75 Hz).
[0104] Comparative Example 1: Traditional single pulse PEMF device, fixed frequency 15 Hz.
[0105] Comparative Example 2: Single-pulse PEMF device with adjustable frequency, frequency range 5-30 Hz.
[0106] Comparative Example 3: Dual-pulse PEMF device, but without precise pulse control and dual-coil design.
[0107] The test method is as follows:
[0108] We selected 20 patients with tibial fractures, 5 in each group, for 8 weeks. All patients received standard fracture fixation. Test indicators included:
[0109] 1. Bone density increase rate: measured using dual-energy X-ray absorptiometry (DEXA).
[0110] 2. Callus volume: measured using CT scan.
[0111] 3. Improvement in pain score: using the visual analogue scale (VAS).
[0112] 4. Inflammatory marker levels: Measure the C-reactive protein (CRP) concentration in serum.
[0113] 5. Treatment compliance: record the percentage of patients completing the scheduled number of treatments.
[0114] The test results are shown in the following table:
[0115]
[0116]
[0117] The test results are analyzed and discussed as follows:
[0118] 1. Bone density increase rate: Example 1 showed the highest bone density increase rate (18.5%), far exceeding the other comparative examples. This may be due to the dual pulse system being able to more effectively stimulate osteocyte activity. The primary output channel (10 Hz) may be primarily responsible for stimulating osteocyte proliferation, while the secondary output channel (75 Hz) may help maintain the sustained activation of osteocytes.
[0119] 2. Increase in callus volume: The callus volume of Example 1 increased most significantly (32.7 cm 3 ). This indicates that the dual pulse system of the present invention not only promotes the increase of bone density, but also accelerates the formation of callus. Precise pulse control (200 microseconds duration, symmetrical rising / falling phases) may play a key role in promoting osteoblast differentiation and mineralization.
[0120] 3. Improvement in pain score: Example 1 performed best in terms of pain relief (68% improvement). This may be because the dual pulse system not only promoted bone healing, but also modulated the sensitivity of pain receptors through the high-frequency pulses (75 Hz) of the secondary output channel.
[0121] 4. Decrease in inflammatory markers: Example 1 showed the most significant decrease in inflammatory markers (72%). This suggests that the dual pulse system may more effectively regulate immune responses and accelerate the resolution of inflammation through the combination of different frequencies.
[0122] 5. Treatment compliance: Example 1 had the highest treatment compliance (95%). This may be due to the user-friendly interface and customizable treatment regimen of the present invention, which makes it easier for patients to adhere to treatment. In addition, the more significant therapeutic effect may also enhance the patient's enthusiasm for treatment.
[0123] The present invention (Example 1) is significantly better than other comparative examples in all test indicators. These results fully verify the superiority of several key innovative points of the present invention:
[0124] 1. Dual pulse system: By providing stimulation of different frequencies simultaneously, more comprehensive and effective cell activation is achieved.
[0125] 2. Precise pulse control: The 200 microsecond symmetrical pulse design may be closer to the natural response characteristics of cells, thereby achieving more effective stimulation.
[0126] 3. Dual coil design: allows more precise control of magnetic field distribution and may be a key factor in achieving better treatment effects.
[0127] 4. Customizable treatment plans: Improve the targeted nature of treatment and patient compliance.
[0128] Based on the above results, Example 1 was determined to be the best example. It not only performed best in promoting fracture healing, but also showed significant advantages in pain management and inflammation control. In addition, high treatment compliance means that this method is more likely to achieve good results in actual clinical applications.
[0129] These results show that the dual pulse induction cell stimulation non-invasive regeneration device of the present invention has significant advantages in the treatment of fracture healing. It not only accelerates the bone repair process, but also effectively manages pain and inflammation, while improving patients' treatment compliance. This comprehensive improvement shows that the present invention has the potential to become an important tool for fracture treatment and even broader regenerative medicine applications.
[0130] Future research directions may include exploring the effects of different frequency combinations on the regeneration of other types of tissues, as well as studying the effects of long-term use on bone strength and microstructure. In addition, given the advantages of the present invention in inflammation control, its potential application in other chronic inflammatory diseases may also be explored.
[0131] It should be noted that the above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the principles of the present invention should be included in the protection scope of the present invention.
Claims
1. Double pulse induction cell stimulation non-invasive regeneration device, It is characterized in that include: a microcontroller for controlling the operation of the device; a power management unit, electrically connected to the microcontroller, for regulating input voltage and supplying power to the device; At least two output channels, each of the output channels comprising: a boost converter for generating an output voltage; an optical coupler for controlling the intensity of the output voltage; MOSFET array for generating output pulse signal; A double coil, electrically connected to the MOSFET array, for generating a magnetic field pulse; a user interface, electrically connected to the microcontroller, for receiving user input and displaying device status; A storage unit is electrically connected to the microcontroller and is used to store treatment plans and device settings.
2. The device according to claim 1, It is characterized in that The at least two output channels include a primary output channel and a secondary output channel, wherein: The main output channel is used to generate pulses of a first frequency; The secondary output channel is used to generate pulses of a second frequency, the second frequency being different from the first frequency; The pulses of the main output channel and the secondary output channel are kept synchronous.
3. The device according to claim 2, It is characterized in that The double coil comprises: A first coil connected to the main output channel; A second coil is connected to the secondary output channel, The first coil and the second coil have the same specifications.
4. The device according to claim 1, It is characterized in that It also includes an SD card interface, which is electrically connected to the microcontroller for data exchange and firmware update.
5. The device according to claim 1, It is characterized in that The user interface includes a touch screen for displaying device status and receiving user input.
6. The device according to claim 1, It is characterized in that The microcontroller is further used to control each of the output channels to generate a pulse with a duration of 200 microseconds, including a rising / positive phase of 100 microseconds and a falling / negative phase of 100 microseconds.
7. The device according to claim 1, It is characterized in that Also included are multiple layers of protection mechanisms, including: Fuse, for over-current protection; TVS diode for overvoltage protection; Schottky diode for reverse voltage protection.
8. The device according to claim 1, It is characterized in that The power management unit includes an LM2733YMF boost converter for operating within an input voltage range of 4.5V to 40V; the MOSFET array includes an IRF7343TRPBF N / P channel MOSFET for fast switching and high efficiency operation; and the optocoupler is a TLP291-4 model for providing electrical isolation and noise suppression.
9. The device according to any one of claims 1 to 8, It is characterized in that The microcontroller is also used to: receiving treatment parameters input by a user; generating a control signal based on the treatment parameter; Sending the control signal to the corresponding output channel, The treatment parameters include pulse frequency, pulse intensity and treatment duration.
10. The device according to any one of claims 1 to 9, It is characterized in that A modular housing is also included for housing the various components of the device and facilitating maintenance and upgrades.
